MoneyWorks4Me

Lupin submits copy of additional clarification

30 Mar 2016 Evaluate

With reference to the news flashed on CNBC TV 18 ‘Mandideep unit inspected by US FDA from 8-19 Feb 2016. US FDA observations at Mandideep unit are serious in nature and the unit gets 483 letter’, Lupin has submitted a copy of additional Clarification.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..